Health Robotics today announced that it has entered the Blood/Plasma Automation Industry by leveraging its technology across the Pharmaceutical and Blood/Plasma industry sectors. They also announced the general availability of embedded Radio-frequency identification (RFID) for its Sterile Compounding Automation solutions i.v.STATION, i.v.SOFT, and i.v.STATION ONCO. These RFID upgrades will be showcased at the upcoming ASHP Midyear Meeting&Exhibition (American Society of Health-System Pharmacists) on December 2-6 in Las Vegas.
Health Robotics' RFID solutions provide a wireless non-contact system that uses radio-frequency electromagnetic fields to transfer data from a tag attached to an object, for the purposes of automatic identification and tracking. The RFID tags contain rich, electronically stored information, which unlike bar-codes, do not need to be within line of sight of the reader and may be embedded in the tracked object, often resulting in faster scans, hands-free operations, massive scanning of multiple objects, and improved workflow and patient safety. Health Robotics' new RFID solutions have been developed through an exclusive cooperation with Techsigno.
Gaspar DeViedma, Health Robotics' Executive V.P. and Board Member, stated, "Health Robotics' RFID solutions allow for a dramatic improvement of the safety of frozen and temperature controlled medications and blood/plasma patient doses through continuous monitoring prior to their expiration dates, including increasing the beyond-use-date for frozen and temperature-controlled medications and blood/plasma patient doses.
"Just as an example of how these new RFID solutions work with one of our Robots, i.v.STATION can optionally embed and automatically affix an RFID tag to the IV Bag or syringe during the printing of the paper label. This is particularly useful for the growing number of Health Robotics' customers that manufacture or plan to manufacture IV Batch products that require temperature control, storage, shipping, and tracking for extended periods of time before final delivery to patients. Centralized Sterile Compounding sites are becoming much more prevalent in the Life Sciences industry as Health Systems move to in-source Sterile Compounding in light of the high cost of traditional outsourced and/or pre-mix solutions, amid the soaring healthcare expenditures and diminishing budgets."